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Abstract Argyrophilic grain disease (AGD), a neurode-
generative disorder, is often associated with mild to moder-
ate Alzheimer’s disease (AD)-related pathology. The
development of dementia in AGD is associated with
the extent of coexisting AD-related pathology. Therefore,
the question arises whether the degenerative changes in the
neuronal network of demented AGD-patients represent a
distinct pattern or show similar changes of disconnection as
considered for AD. We were able to apply DiI-tracing in
two human autopsy cases with mild AD-related pathology
(controls), in one AD-patient, in one non-demented patient
with advanced AD-related pathology, and in three cogni-
tively impaired AGD-patients. DiI-crystals were injected
into the entorhinal cortex. Pyramidal neurons of layers III
and V of the adjacent temporal neocortex (area 35) were
retrogradely marked with the tracer and analyzed. The AD
case did not exhibit any retrogradely labeled neurons in the
temporal neocortex. In the non-demented case with
advanced AD-related pathology, the number of traced neu-
rons was reduced as compared to that in the two controls
and in the three AGD cases. In contrast, all three cogni-
tively impaired AGD cases exhibited labeled pyramidal
neurons in area 35 in an almost similar number as in the
controls. However, alterations in the dendritic tree were
observed in the AGD cases. These results show the exis-
tence of temporo-entorhinal connections in the adult human
brain similar to those reported in animal models. Further-
more, the present study based on seven cases is the Wrst
attempt to study changes in the neuronal network in a
human tauopathy with targeted axonal tracing techniques.
Our Wndings in three cognitively impaired AGD cases sug-
gest that AGD-related dementia constitutes a distinct
disorder with a characteristic pattern of degeneration in the
neuronal network.
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Introduction
Alzheimer’s disease (AD) and argyrophilic grain disease
(AGD) are dementing disorders, which lead to degeneration
of the medial temporal lobe [2, 4, 5, 29]. Although both dis-
orders are tauopathies they diVer in the type of tau-lesions
and in the types of neurons aVected [4]. NeuroWbrillary tan-
gles (NFTs), neuropil threads, neuritic plaques as well as
neuronal loss prevail in AD, whereas argyrophilic grains,
oligodendroglial coiled bodies, ballooned neurons and tau-
positive astrocytes are hallmarks of AGD [3, 4, 41]. The
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role of AGD for the development of dementia is controver-
sially discussed. Some reports showed patients in whom
dementia was explained by AGD although low levels of
AD-related changes also prevailed [4, 31, 38]. On the other
hand, dementia in AGD-patients was more frequently seen
in association with moderate to severe AD-related changes
than in those with less severe AD-related pathology [22,
36]. Therefore, the question arises whether AGD is a dis-
tinct type of dementia or AD with additive pathological
changes [22].
We were able to apply DiI-tracing in seven autopsy
cases with mild AD-related pathology, with moderate to
severe AD-related pathology, AD, and with AGD-related
cognitive deWcits. Here, we studied the pattern of altera-
tions in temporo-entorhinal association neurons in AGD.
Temporo-entorhinal association neurons connect two
regions, which are aVected early in the course of AD and
AGD, and in close anatomical proximity. These Wbers have
been described in monkeys [19, 43]. To our knowledge,
their existence has not been demonstrated in the adult
human brain until now. Only single neurons have been
traced in fetal human brain [14]. Here, we were able to
show this Wber tract in the human adult brain and to study
its involvement in AGD.
Materials and methods
Clinical and neuropathological characterization
Seven brains from human autopsy cases with a postmor-
tem-interval ranging from 6 to 23 h (mean 12 h) were used
for DiI-tracing (Table 1). Selection criteria were postmor-
tem-intervals of <24 h and the possibility to dissect the
entire left medial temporal lobe for tracing from the unWxed
brain as previously published [12]. Demented as well as
non-demented patients had been examined 1–4 weeks prior
to death according to standardized protocols used for rou-
tine clinical and neurological examination of patients upon
admission to the hospital. Protocols included the assess-
ment of cognitive function and recorded the ability to care
for and dress oneself, eating habits, bladder and bowel con-
tinence, speech patterns, writing and reading skills, short-
term and long-term memory, and the orientation within the
hospital setting. These data were used to retrospectively
apply the clinical dementia rating (CDR) test [18] as well as
the global deterioration scale (GDS) test [30]. Using these
data it was examined whether individuals clinically fulWlled
the DSM-IV criteria for dementia [1] or not. AD was diag-
nosed when dementia was observed and AD-related pathol-
ogy at autopsy fulWlled recommended criteria for the
diagnosis of AD [37].
Except for the left medial temporal lobe, which was used
for DiI-tracing, brains were Wxed in a 4% aqueous formal-
dehyde solution for at least 3 weeks. Blocks of the right
MTL were taken at the levels of the (1) anterior limit of the
dentate gyrus, (2) lateral geniculate body, and (3) posterior
limit of the dentate gyrus [20]. The tissue blocks were
embedded in polyethylene glycol (PEG) [6] and in paraYn.
The PEG-blocks were microtomed at 100 m, whereas the
paraYn sections were cut at 10 m.
NeuroWbrillary changes and argyrophilic grains were
detected using the Gallyas-silver-staining method [6, 21].
Abnormal phosphorylated tau-protein was recognized with
a monoclonal antibody (AT-8; Innogenetics; Belgium; 1/
1,000). The presence of amyloid deposits was assessed
using the Campbell–Switzer silver impregnation method [6,
21] and/or using immunohistochemistry with an antibody
directed against A17–24 (4G8; Signet; Dedham; USA; 1/
5,000; formic acid pretreatment). For topographical orien-
tation and neuropathological diagnosis, serial paraYn and
PEG sections were stained with aldehydefuchsin-Darrow-
Table 1 List of cases with neuropathological and clinical results and type of neurodegeneration as determined by DiI-tracing
F female, M male, AD Alzheimer’s disease, ADRP non-demented with AD-related pathology, AGD argyrophilic grain disease, 0 no neurodegen-
eration, and PMI postmortem-interval (h)
NFT (Braak)-stage according to [5], CERAD-score according to [24], A-phase according to [35], clinical dementia rating score (CDR) according
to [25], and global deterioration scale (GDS) according to [30]
Case 
number
Age Gender NFT 
(Braak)-stage
CERAD-
score
A-phase CDR GDS Diagnosis Type of 
neurodegeneration
Number of 
traced association 
neuron in area 35
PMI
1 91 F 2 0 1 0 1 ADRP 0 18 6
2 90 F 3 0 1 0 1 ADRP 0 12 11.5
3 77 M 3 A 2 0.5 3 AGD AGD-dendritic degeneration 13 12
4 80 F 2 A 3 1 6 AGD AGD-dendritic degeneration 8 12
5 81 M 2 A 3 2 6 AGD AGD-dendritic degeneration 12 9
6 87 F 4 B 3 3 6 AD AD-disconnection 0 23
7 67 M 4 A 4 0 1 Severe ADRP AD-disconnection 5 12.5Acta Neuropathol (2008) 115:175–183  177
123
red for lipofuscin pigment and Nissl material. Cyto- and
pigmentoarchitectural parcellations of the entorhinal layers
were performed according to Braak and Braak [7]. Diagno-
sis of the stages in the development of neuroWbrillary
changes (Braak-stage) was performed in accordance with
published criteria [5, 37]. The frequency of neuritic plaques
(CERAD-score) was assessed as recommended by Mirra
et al. [24] using Gallyas-stained sections. For the Braak
staging and CERAD-scores additional sections from the
occipital cortex, including the primary visual cortex, were
analyzed. For staging of A-pathology, we used the
recently described four phases of -amyloidosis in the
MTL [34]. This hierarchy based procedure enables us to
explore the expansion of A-deposition into additional
brain regions [34, 35]. Phase 1 represents A-deposits that
are restricted to the temporal neocortex. Phase 2 is charac-
terized by additional A-plaques in the entorhinal cortex
and/or in the subiculum-CA1 region. The third phase of
-amyloidosis exhibits additional A-plaques in the outer
zone of the molecular layer of the fascia dentata, subpial
band-like amyloid and/or the presubicular “lake-like” amy-
loid. The presence of additional A-plaques in CA4 and/or
the pre--layer of the entorhinal cortex marks the fourth
and Wnal phase of A-deposition.
Diagnosis of AGD was based on the detection of argyro-
philic grains in the Gallyas-stained sections and on the
presence of coiled bodies, tau-positive astrocytes, and bal-
looned neurons exhibiting abnormal tau protein [4, 41].
Tissue preparation and DiI-tracing
The unWxed brain was cut into frontal slabs of approxi-
mately 10 mm thickness. At the level of the entorhinal
region and the uncus formation, the left medial temporal
lobe including the hippocampal formation, entorhinal
region, and adjacent temporal neocortex (areas 35 and 36)
was cut and immediately Wxed in 0.1 M phosphate buVered
saline (PBS) (pH 7.4) containing 2.6% paraformaldehyde
(PFA), 0.8% iodoacetic acid, 0.8% sodiumperiodate, and
0.1 M D-L Lysine for 5 days as previously published [12].
After 5 days, a single DiI-crystal (Molecular Probes,
Eugene, OR, USA) was implanted into the entorhinal layers
(Fig. 1) as described previously [9,  12]. One DiI-crystal
was placed into each side of the sample to ensure tracing of
neurons in the entire sample. In order to ensure that the
injection sizes were of similar extent in all cases, individual
dye crystals were glued to the tip of a glass capillary using
ethanol and then measured under a microscope before
implantation. For injection, dye crystals exhibiting a diame-
ter of about 500 m were selected. Postmortem tracing with
DiI allows a precise Golgi-like tracing of neurons in Wxed
tissues with a quality similar to that of in vivo tracing tech-
niques such as biotinylated dextrane amines or rhodamine
labeled latex microspheres in combination with intracellu-
lar  Wlling with Lucifer Yellow [11]. After incubation in
2.0% phosphate buVered PFA for at least 12 months at
37°C, 100 m thick coronal vibratome sections were cut.
Sections were mounted in TBS for microscopic analysis.
Microscopic and quantitative analysis
Every third section of the medial temporal lobe samples of
each human autopsy case was examined using a Leica
DMLB Xuorescence microscope. The distance between the
tracer application site in the entorhinal cortex and area 35
was approximately 6–9.5 mm. Ten sections of the level of
the implanted tracer were used to quantify the number of
traced pyramidal neurons in layer III and layer V of the
temporal neocortex in Brodmann area 35. This part of the
neocortex adjoins the entorhinal region (area 28). Associa-
tion Wbers connect both regions. The transentorhinal region
sets the boundary between these regions (Fig. 1). In cases
where no labeled neurons were detected, it was determined
whether at least labeled neurites could be found. In the
event that retrogradely labeled neurons were present, the
number of stained pyramidal neurons in area 35 was
assessed in ten subsequent sections cut at a thickness of
100 m. Thus, the number of neurons in a 1-mm-thick slab
of the area 35 was determined. Then, the dendritic tree of
labeled neurons was investigated. Primary and secondary
branches of the dendritic tree were analyzed. A laser scan-
ning confocal microscope (Leica TCS NT, Leica, Bens-
heim, Germany) was used. Stacks of 2D images were
superimposed digitally using the Image J Imaging Process-
ing and Analysis software (NIH, Bethesda, MD, USA), and
3D data sets were generated for the visualization of neurons
with their entire dendritic tree.
Fig. 1 Schematic representation of postmortem tracing with DiI. DiI-
crystals (arrow) were injected into the upper layers of the entorhinal
cortex (area 28). Pyramidal neurons of the adjacent temporal cortex
of area 35 (cortex in the boxed area) were retrogradely traced in the
control cases. TER transentorhinal region178 Acta Neuropathol (2008) 115:175–183
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Results
DiI application into the entorhinal cortex of the two non-
demented patients with low levels of AD-related pathology
(controls) marked a high number of neurites projecting into
area 35 of the temporal cortex as well as 12–18 retrogradely
labeled pyramidal neurons in layers III and V in a 1-mm-
thick slab of the area 35 (Figs. 2, 3; Table 1). The number
of neurons per section varied between 0 and 4. The neurons
were, thereby, organized in clusters of 2–3 in one section
(Fig. 2b, c). These neurons showed a symmetric dendritic
tree with basal dendrites of similar size (Fig. 3). The proxi-
mal parts of the basal dendrites showed larger calibers than
the distal parts. Neurons from other parts of the temporal
cortex were not traced.
The cognitively impaired AGD cases with moderate lev-
els of AD-related pathology exhibited 8–13 retrogradely
traced neurons in a 1-mm-thick slab of area 35 (Fig. 2,
Table 1). At higher magniWcation, these neurons displayed
alterations of their dendritic tree. Although the dendritic
tree exhibited a symmetric pattern, a high number of basal
dendrites of layers III and V pyramidal neurons showed
proximal caliber thinning not seen in controls (Fig. 3). The
dendritic spines were more prominent in the AGD cases
than in the two control cases and the dendrites exhibited a
“clumsy” pattern. The existence of “clumsy” structures in
contact with the branches of the dendrites was conWrmed by
analyzing 3D-reconstructions of the dendrite with the con-
focal laser scan microscope excluding dendritic beading as
well as artiWcial beading (Fig. 3g–k). The morphology of
the “clumsy” spines was similar to that of abnormal phos-
phorylated tau-protein in argyrophilic grain disease-aVected
neurons (Figs. 4c, 5).
In the non-demented Braak-stage-IV A-phase-4 case
lacking AGD-pathology, only Wve neurons were retro-
gradely labeled in a 1-mm-thick slab of the area 35. The
dendrites of these neurons did not exhibit “clumsy”
changes as seen in the AGD cases (Fig. 3f). In the AD cases
there was no retrograde tracing of pyramidal neurons in the
temporal cortex of area 35. However, the sparse presence of
individually stained neurites indicated that the tracing had
in principle been successful (Figs. 2, 3c; Table 1).
Based on these results, we distinguished diVerent types
of neurodegeneration as provided in Table 1: (1) no neuro-
degeneration, i.e., neurons traced in area 35 exhibit a regu-
lar dendritic tree; (2) dendritic degeneration, i.e., neurons
with traced basal dendrites showing proximal caliber thin-
ning and “clumsy” spines in area 35; and (3) neuronal dis-
connection, i.e., more than 50% reduction of the traced
association neurons in the association cortex.
The Gallyas-silver-staining revealed a high number of
NFTs in area 35 of the Braak-stage-IV cases while only sin-
gle NFTs were found in control and AGD cases with lower
Braak-stages (II and III) (Fig. 4). The Gallyas-stained tem-
poral neocortex of both Braak-stage-III cases is depicted in
Fig. 4e, f showing only single NFTs, whereas numerous
NFTs were found in the Braak-stage-IV case (Fig. 4g). The
three AGD cases revealed grains (Fig. 4b), coiled bodies,
tau-positive astrocytes, neurons (Fig. 4c), and ballooned
neurons in sections stained for abnormal phosphorylated
tau-protein. Only a few grains and coiled bodies were seen
in Gallyas-silver-stained sections. Similarly, the two cases
with neuronal disconnection exhibited higher phases of A-
deposition than cases with traceable neurons in area 35.
Fig. 2 Disconnection of the entorhinal–temporal association Wber tract
in an AD case but not in cognitively impaired AGD and control cases.
a DiI-tracing of entorhinal–temporal connections in the control case
(case No. 2) exhibited DiI-labeled structures in area 35 of the temporal
neocortex (arrows). b Detailed view into the temporal cortex of area 35
of the control case. Here, a group of three neurons (arrows) was la-
beled. One neuron (boxed area) is enlarged in c. The cell soma and the
basal dendrites were traced (arrow). d A similar pattern of traced neu-
rons was seen in the cognitively impaired AGD case (arrows; case
No. 3). e The detailed view into area 35 showed a cluster of two neurons
(arrows). One neuron (boxed area) is enlarged in f showing the soma
with the dendritic tree (arrow). ArtiWcially stained material was in con-
tact with the neuron and is indicated by an asterisk. g No DiI-labeling
of association Wbers in the temporal cortex of the AD case (arrows; case
No. 6). h Only single neurites (arrow in h and i) were detectable in
the entorhinal cortex (boxed area) and are enlarged in i and Fig. 3c.
Calibration bar g valid for a, d, and g; and h valid for c, f, and hActa Neuropathol (2008) 115:175–183  179
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Moreover, the cases with dendritic degeneration had higher
phases of A-deposition than the controls with only mild
AD-related pathology (Table 1).
Discussion
DiI-tracing into the entorhinal cortex demonstrated that
temporo-entorhinal connections exist in the adult human
brain similar to that described in animals earlier [19, 43].
These association Wbers arise from pyramidal cells in layers
III and V of the area 35. As reported for other interhemi-
spheric connections [12, 32], temporo-entorhinal connec-
tions also arise from small clusters of temporal neurons
presumably representing the modular architecture of the
cerebral cortex. The distribution of these clusters varied
among diVerent sections of the same individual and
explains the variation of labeled neurons between individual
cases. Association Wbers from other parts of the temporal
cortex have not been observed.
Fig. 3 Degeneration of dendrites in traced temporal layer III pyrami-
dal neurons of area 35 of the temporal cortex. To analyze the integrity
and structure of the dendrites stacks of ten images obtained by confocal
laser scan microscopy in »10 m distance were superimposed in a Z-
project or analyzed in a 3D-project using the image J software. a Z-pro-
ject. The pyramidal neurons of the non-demented control case (case
No. 2) showed a symmetric dendritic tree with branching basal den-
drites. The distal branches (large arrows) were smaller than the proxi-
mal ones (small arrows). The boxed area in a is enlarged in d. At high
power magniWcation, only small spine-like structures were seen
(arrows in d). b Z-project. The cognitively impaired AGD case (case No.
3) showed neurons with thin proximal basal dendrites (small arrows).
The distal dendrites often appeared to have a similar or larger diameter
(large arrows). High power laser-scan microscopy (boxed area e, en-
larged in e) revealed prominent clumsy spines on the basal dendrites
(arrowheads in e). c Fluorescence microscopy. The AD case No. 6 did
not show labeling of neurons. Only few single neurites (arrows) were
traced in the entorhinal cortex near the tracer application site indicating
severe degeneration of the local neuronal network. f Z-Project. A sur-
viving association neuron in the temporal neocortex of the non-
demented case with severe AD-related pathology (case No. 7) showed
basal dendrites without clumsy spines in a pattern similar to non-AD
cases with mild AD-related pathology a, d. The proximal dendrites
(small arrows) were thicker than the distal ones (large arrows). g–i
Confocal images at three diVerent levels indicate that there is no obvi-
ous dendritic beading (arrows in g–i). Three dimensional reconstruc-
tion presented in two diVerent perspectives conWrming the absence of
dendritic beading (arrows in j, k). Clumsy dendritic spines were iden-
tiWed (arrowheads in g–i) and conWrmed by 3D reconstruction (arrow-
heads in j, k). Calibration bar c valid for a–c; e valid for d and e; and
k valid for g–k180 Acta Neuropathol (2008) 115:175–183
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Within seven cases examined in the present study using
postmortem tracing with DiI, a disconnection of association
Wbers between the entorhinal and the adjacent temporal
neocortex was seen in an AD case and in one non-demented
case with Braak-stage-IV AD-related pathology. By con-
trast, all cognitively impaired patients with AGD-pathology
did not exhibit obvious disconnection between the entorhinal
and the temporal neocortex. However, they displayed
dendritic tree abnormalities as compared to the two non-
demented cases with mild AD-related pathology lacking
AGD and to the non-demented case with severe AD-related
pathology.
To our knowledge, this is the Wrst report showing dis-
connection in an AD brain with a tracing technique and
demonstrating intact connectivity in cognitively impaired
patients with AGD. Only dendritic alterations were found
in AGD. However, one obvious limitation of this study is
its small sample size. Given the manifold prerequisites for
successful postmortem tracing [12], i.e., (1) postmortem-
interval <24 h, (2) preparation and Wxation for tracing at
autopsy, and (3) a 10-mm-thick piece of the medial tempo-
ral lobe received from research cases not included into a
speciWc brain bank protocol, the number of available cases
for such tracing experiments was very low.
DiI-tracing is a postmortem tracing technique, which has
already been successfully used to study connections in the
human autopsy brain with a postmortem delay up to and
including 24 h [12, 14, 27, 32]. This technique labels all
cells retrogradely and anterogradely in a Golgi-like pattern
by diVusion in membrane structures, which are in touch
with the tracer [16, 17]. In animals, it has been shown that
this technique labels all processes of a stained neuron as if
Fig. 4 a The Gallyas-silver-stained section of the control case No. 2
with Braak-stage-III conWrmed the presence of single NFTs (arrows)
in CA1. b Using an antibody, directed against abnormal tau-protein,
argyrophilic grains (arrows) were predominant in the temporal neocor-
tex (area 35) of the AGD case No. 3. c The Z-project of three images
of »10 m focus distance showed a neuron of the same AGD case
exhibiting abnormal phosphorylated tau-protein with clumsy, grain-
like structures in the basal dendrites (arrows). d The AD case (case No.
6) exhibited high numbers of Gallyas-positive NFTs (arrows) and a
neuritic plaque (arrowhead) in CA1. e, f In the temporal cortex of area
35 in the control (e; case No. 2) and in the AGD-brain (f; case No. 3)
only single neurons of layer V contained Gallyas-positive neuroWbril-
lary material (arrows). g In the AD case a large number of Gallyas-pos-
itive NFTs (arrows) were seen in layers III, V, and VI as compatible
with Braak-stage-IV and higher. TI temporal neocortex of area 35 and
CA1 Ammon’s horn sector CA1. Calibration bar b valid for a and b;
d valid for c and d; and g valid for e–g
Fig. 5 Schematic representation of temporal–entorhinal connectivity
in control, AGD and AD brain. In aged controls with minimal AD-
related changes temporal and entorhinal cortices are connected. Typical
pyramidal neurons project into the entorhinal cortex. In AGD temporal
and entorhinal cortices are connected but the projecting pyramidal neu-
rons display dendritic alterations (marked in red). Axonal disconnec-
tion is seen in AD. Neurons, which once were connected, are no longer
detectable with DiI-tracing (scattered neurons marked in red). The red-
labeled parts of the association neurons were obviously altered in AGD
and AD, respectively. Disconnection in AD can most likely be ex-
plained as the result of neuronal loss [5, 13, 15, 26, 33]Acta Neuropathol (2008) 115:175–183  181
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it is marked with a rhodamine tracer [11] and that the pat-
tern of the traced neurons is similar to that detected by in
vivo tracing with biotinylated dextrane [9]. By this, the
tracing method leads to valid results in postmortem tissue
when applied shortly after death as done in the cases stud-
ied here.
The reduction of the number of tracer-labeled associa-
tion neurons in area 35 in the AD case and in the non-
demented Braak-stage-IV case indicates that there was a
disconnection between the temporal cortex of area 35 and
the entorhinal cortex. Since single neurites and neurons
were marked, the tracing was considered to be successful.
Therefore, insuYcient tracing is unlikely to explain the
reduction of connectivity. Our Wnding of disconnection in
the temporal cortex is in line with the decrease of axonal
transport reported in the temporal neocortex of AD-patients
[10]. Since neuroWbrillary pathology and neuronal loss start
in the transentorhinal–entorhinal cortex and subsequently
involve the basal temporal neocortex in Braak-stage-IV [5,
13], the onset of disconnection in this early aVected part of
the brain may be explained by the aVection of the local
pyramidal neurons by neuroWbrillary pathology and neuro-
nal loss [5, 13, 33]. In the Braak-stage-II and III cases stud-
ied here, there was only mild aVection of single neurons
carrying NFTs in the temporal association cortex explain-
ing the preservation of connectivity in the non-demented
and AGD cases. Based on the results of clinico-pathologi-
cal correlation studies, Hof et al. [15,  26] suggested that
neuronal disconnection is involved in the development of
cognitive decline in AD. The absence of traceable temporo-
entorhinal connections in our AD case supports this
hypothesis. The presence of multiple NFTs in the temporal
neocortex of the Braak-stage-IV AD case further indicates
severe damage of the neurons in the area 35.
By contrast, anatomical disconnection is not a prerequi-
site for developing dementia in all tauopathies. All of the
three cognitively impaired or demented AGD cases studied
here exhibited no substantial anatomical disconnection.
Neurons in area 35 were traced in an almost similar quan-
tity as in the two non-demented elderly brains with mild
AD-related pathology. Moreover, neuronal loss or brain tis-
sue loss responsible for tissue shrinkage is often not detect-
able in AGD cases [41], which has been suspected to
underlie the AD-related disconnection [15]. However, the
pattern of the dendritic tree pathology in AGD diVered
from that in the non-demented non-AGD cases. In the
demented AGD cases, proximal thinning of basal dendrites
as well as clumsy spines was seen but these changes were
absent in non-AGD cases. Dendritic beading, which may
also explain a “clumsy” pattern of the dendrites due to exci-
totoxic events [28], could be excluded by 3D-reconstruc-
tion of serial scans with the laser scan microscope through
the 100-m-thick section. Even though the connectivity
seemed to be intact as indicated by retrogradely labeled
neurons, the observed changes in the morphology of den-
drites in AGD cases may thus lead to functional deWcits
underlying dementia. This pattern of predominant dendritic
changes in AGD reXects the pattern of tau and argyrophilic
pathology in this disease. Only grains and glial inclusions
are argyrophilic in AGD [8]. Abnormal phosphorylated tau-
protein, however, occurs in neurons but it shows in addition
to a somatic distribution, a characteristic staining of spines
often exhibiting a clumsy, grain-like appearance [39].
Comparison of the three cognitively impaired AGD-
patients with the patients with severe AD-related pathol-
ogy or AD points to distinct diVerences in the pattern of
neurodegeneration between AGD and AD. The AD-type
of dementia is suggested to receive its major morphologi-
cal correlation by anatomical disconnection as reported
earlier [15], whereas AGD-related cognitive impairment
appears to be due to dendritic degeneration preserving the
axonal connections (Fig. 5). The lack of similar AGD-like
dendritic alterations in non-disconnected association neu-
rons of the case with severe AD-related pathology further
supports that distinct dendritic alterations occurred in the
AGD cases. Recently, others and we have shown that
demented AGD cases have more severe additional AD-
related pathology than non-demented AGD cases [22, 36].
Josephs et al. [22] hypothesized that AGD may not be a
distinct disorder but AD with additive pathology. The
existence of our three cognitively impaired cases with
AGD showing a pattern of alterations in the neuronal net-
work diVerent from that seen in an AD case argues against
this hypothesis. Thus, our tracing study supports the con-
cept of other authors [4, 23, 31] that AGD is a distinct
neurodegenerative disorder. However, the coexistence of
AGD and AD pathologies in the brain will lead to additive
eVects of both degenerative mechanisms lowering the
threshold for developing dementia for each of the two
pathologies as reported earlier [36].
The extent to which A-aggregates, which were seen in
all of our demented AGD cases studied here, induce den-
dritic changes in AGD-brains, is still debatable. Animal
experiments showing dendritic alterations induced by A-
aggregates [9, 42, 44] are in support of this notion. The
coexistence of A-deposits in the brain of cognitively
impaired AGD cases can be interpreted along the same line
[22,  36,  40]. However, further studies are required to
address the contribution of A to AGD-like neurodegenera-
tion.
In summary, this report of seven cases shows that den-
dritic alteration but not anatomical disconnection character-
izes AGD. This type of neurodegeneration is opposed by
the concept of anatomical disconnection in AD [15], which
is supported by our tracing results in cases with advanced
AD-related pathology and AD (Fig. 5).182 Acta Neuropathol (2008) 115:175–183
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